Silmitasertib 25 mg | 99.47%
TargetMol
CX-4945 is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
More Information Supplier PageSilmitasertib
Search Results
Doramapimod 50 mg | 99.65%
TargetMol
Doramapimod is a highly potent inhibitor of p38 MAPK (Kd: 0.1 nM), but weakly inhibits c-RAF, Fyn, Lck, ERK-1, SYK, IKK2, and ZAP-70.
More Information Supplier PageDoramapimod
Doramapimod 10 mg | 99.65%
TargetMol
Doramapimod is a highly potent inhibitor of p38 MAPK (Kd: 0.1 nM), but weakly inhibits c-RAF, Fyn, Lck, ERK-1, SYK, IKK2, and ZAP-70.
More Information Supplier PageDoramapimod
Silmitasertib 5 mg | 99.47%
TargetMol
CX-4945 is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
More Information Supplier PageSilmitasertib
Silmitasertib 50 mg | 99.47%
TargetMol
CX-4945 is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
More Information Supplier PageSilmitasertib
Silmitasertib 2 mg | 99.47%
TargetMol
CX-4945 is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
More Information Supplier PageSilmitasertib
Silmitasertib 10 mg | 99.47%
TargetMol
CX-4945 is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
More Information Supplier PageSilmitasertib
VO-Ohpic trihydrate 25 mg | 100.00%
TargetMol
VO-Ohpic is a potent inhibitor of PTEN (phosphatase and tensin homolog) with IC50 of 35 nM.
More Information Supplier PageVO-Ohpic trihydrate
VO-Ohpic trihydrate 100 mg | 100.00%
TargetMol
VO-Ohpic is a potent inhibitor of PTEN (phosphatase and tensin homolog) with IC50 of 35 nM.
More Information Supplier PageVO-Ohpic trihydrate
VR23 10 mg | 99.62%
TargetMol
VR23 is a potent proteasome inhibitor. Data shows IC50 =1 nM for trypsin-like proteasomes, IC50=50-100 nM for chymotrypsin-like proteasomes, and IC50=3 μM for caspase-like proteasomes.
More Information Supplier PageVR23
